作者: Yan Zhou , Yuan Su , Baolin Li , Feng Liu , John W Ryder
关键词:
摘要: A subset of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to preferentially reduce the secretion highly amyloidogenic, 42-residue amyloid-beta peptide Abeta42. We found that Rho and its effector, Rho-associated kinase, regulated amount Abeta42 produced in vitro only those NSAIDs effective as inhibitors lowered Administration Y-27632, a selective Rock inhibitor, also brain levels transgenic mouse model Alzheimer's disease. Thus, Rho-Rock pathway may regulate amyloid precursor protein processing, can through inhibition activity.